The nitrate ingested over the course of a person’s adult lifetime through the consumption of tap water and bottled water could be a risk factor for prostate cancer, particularly in the case of ag...
Read more
Scientists from the Oncology area of the Biosanitary Research Institute of Granada relate exposure to Bisphenol A with an increased risk of developing prostate cancer
Read more
PARP inhibitors (PARPi) are approved for treating advanced prostate cancers with various defective DNA repair genes, although not all patients derive the same benefit from this targeted therapy.
Read more
One in eight men will be diagnosed with prostate cancer at some point in their lifetime. Several treatments for this type of cancer are currently available, but the tumour develops resistance and the ...
Read more
Researchers of the Human Molecular Genetics group at the Bellvitge Biomedical Research Institute (IDIBELL), led by Dr. Sara Larriba, in collaboration with Dr. Francesc Vigués and Dr. Manel Castells o...
Read more
Published this month in the International Journal of Radiation Oncology, Biology, Physics*, findings first authored by Joan Carles, Principal Investigator of VHIO’s Genitourinary, CNS Tumors, Sar...
Read more
Published in the Journal of Clinical Oncology, the study has potential implications for families with members suffering from these two types of tumours who are at an increased risk of developing cance...
Read more
US$2 million of DoD funding to support a project counting on the multidisciplinary expertise of researchers and physician scientists at VHIO, the Spanish National Cancer Research Centre and the Univer...
Read more
A study led by Dr. Rosanna Paciucci, principal investigator of the Biomedical Research Group in Urology of the Vall d'Hebron Research Institute (VHIR), points to the PTOV1 protein as a potential new t...
Read more
A team led by researchers of the Institute of Biomedicine of the University of Barcelona (IBUB) and the Research Institute of the Hospital de la Santa Creu i Sant Pau (IIB Sant Pau) shows for the fi...
Read more
The expression of a central regulator of cell metabolism, PGC1A is associated with prostate cancer aggressiveness. The research paves the way for the identification of patients at risk of developing m...
Read more
The detection of TMPRSS2-ERG in the blood of patients with resistant metastatic prostate cancer predicts resistance to taxanes, such as docetaxel, and may be useful for selecting the best treatment op...
Read more
AtCDF3 gene induced greater production of sugars a...
Un estudio con datos de los últimos 35 años, ind...
Un equipo de investigadores de la Universidad Juli...
En nuestro post hablamos sobre este interesante tipo de célula del...
Palobiofarma S.L. is pleased to announce the “last patient last visi...
